| Indicators | Browse All

Labcorp Holdings Inc. (LH)

Healthcare | Diagnostics & Research | Burlington, United States | NYSE
335.11 USD -0.71 (-0.211%) ⇩ (Aug. 28, 2026, 4 p.m. EDT)
After hours: 333.00 -2.11 (-2.110%) ⇩ (Aug. 28, 2026, 7:41 p.m. EDT)

Short-term:★★★★☆Long-term:★★★★☆Dividends:★★⯪☆☆
Hot Take | Aug. 22, 2026, 3:30 a.m. EDT

The long-term investment case is exceptionally strong, backed by a nine-year price trajectory that has climbed over 130 percent and consistent earnings growth exceeding 25 percent. While the current valuation is not cheap, the business quality justifies a premium, and the forward P/E suggests meaningful earnings expansion ahead. On the short end, momentum is building with the stock trading near its fifty-two-week high, supported by recent guidance raises and positive analyst sentiment. However, the statistical forecasting model offers a neutral outlook, creating a tension where the fundamental and technical signals suggest strength while the price noise model remains quiet. The dividend yield is modest but highly sustainable, serving as a floor rather than a primary driver of return.

Model Selection — Backtest MAE (log-scale, lower is better)
ModelMAE
AutoETS ✓0.067184
MSTL0.067321
AutoARIMA0.068250
AutoTheta0.083800

Forecast horizon: 45 days | Selected: AutoETS

Forecast Reliability
Score 45%
H-stat 48.93
Ljung-Box p 0.000
Jarque-Bera p 0.186
Excess Kurtosis -0.49
Attribute Value
Sector Healthcare
Ex Dividend Date 2026-08-27
Last Dividend Date 2026-05-28
Debt to Equity Ratio 79.124
Revenue per Share 174.021
Market Cap 27,177,420,800
Trailing P/E 27.86
Forward P/E 16.93
Beta 0.84
Profit Margins 6.99%
Previous Name Laboratory Corporation of America Holdings
Website https://www.labcorp.com

As of Aug. 22, 2026, 3:30 a.m. EDT: Speculators are positioning for long-term upside with significant call volume in early 2027, while establishing downside protection via heavy put volume in November 2026. Implied volatility remains moderate across expirations.


Dividend Data

Yield Summary
Last Yield 1yr Yield 3yr Avg 5yr Avg
0.21% 1.27% 1.17% 1.07%
Dividend History
Date Dividend Yield %
2026-08-28 0.720000 0.214855
2026-05-29 0.720000 0.276859
2026-02-27 0.720000 0.249032
2025-11-26 0.720000 0.268386
2025-08-28 0.720000 0.261542
2025-05-29 0.720000 0.291793
2025-02-27 0.720000 0.290569
2024-11-26 0.720000 0.301596
2024-08-29 0.720000 0.313466
2024-05-24 0.720000 0.360631
2024-02-26 0.720000 0.334153
2023-11-07 0.720000 0.347877
2023-08-07 0.720000 0.335821
2023-05-17 0.618557 0.331675
2023-02-22 0.618557 0.297042
2022-11-16 0.618557 0.295324
2022-08-17 0.618557 0.284248
2022-05-18 0.618557 0.296969
1994-03-29 0.171821 0.592592
1993-12-29 0.171821 0.576576
1993-09-29 0.171821 0.516128
1993-06-29 0.171821 0.444444
1993-03-31 0.171821 0.467152
1992-12-29 0.171821 0.453900
1992-09-28 0.171821 0.402515
1992-06-26 0.171821 0.407643
1992-03-31 0.150344 0.282829
1992-01-06 0.150344 0.256881
1991-09-30 0.150344 0.327486
1991-06-27 0.150344 0.363637
1991-04-04 0.128866 0.313726
1990-12-31 0.128866 0.545455
Additional Data
dividendRate 2.88
dividendYield 0.86
exDividendDate 2026-08-28
trailingAnnualDividendRate 2.88
trailingAnnualDividendYield 0.008576023
lastDividendValue 0.72
lastDividendDate 2026-05-29
dividendDate 2026-09-11

Info Dump

Attribute Value
52 Week Change 0.22923517
Address1 531 South Spring Street
All Time High 341.8
All Time Low 2.416237
Ask 336.19
Ask Size 120
Audit Risk 3
Average Analyst Rating 1.7 - Buy
Average Daily Volume10 Day 639,280
Average Daily Volume3 Month 672,611
Average Volume 672,611
Average Volume10Days 639,280
Beta 0.843
Bid 314.61
Bid Size 80
Board Risk 7
Book Value 106.388
City Burlington
Compensation As Of Epoch Date 1,767,139,200
Compensation Risk 3
Country United States
Crypto Tradeable 0
Currency USD
Current Price 335.11
Current Ratio 1.796
Custom Price Alert Confidence HIGH
Date Short Interest 1,786,665,600
Day High 337.69
Day Low 334.42
Debt To Equity 79.124
Display Name Labcorp
Dividend Date 1,789,084,800
Dividend Rate 2.88
Dividend Yield 0.86
Earnings Call Timestamp End 1,785,416,400
Earnings Call Timestamp Start 1,785,416,400
Earnings Growth 0.282
Earnings Quarterly Growth 0.256
Earnings Timestamp 1,785,414,600
Earnings Timestamp End 1,793,709,000
Earnings Timestamp Start 1,793,709,000
Ebitda 2,319,800,064
Ebitda Margins 0.16168
Enterprise To Ebitda 14.603
Enterprise To Revenue 2.361
Enterprise Value 33,875,021,824
Eps Current Year 18.34577
Eps Forward 19.79822
Eps Trailing Twelve Months 12.03
Esg Populated 0
Ex Dividend Date 1,787,875,200
Exchange NYQ
Exchange Data Delayed By 0
Exchange Timezone Name America/New_York
Exchange Timezone Short Name EDT
Fifty Day Average 298.0212
Fifty Day Average Change 37.088776
Fifty Day Average Change Percent 0.124450125
Fifty Two Week Change Percent 22.923517
Fifty Two Week High 341.8
Fifty Two Week High Change -6.6900024
Fifty Two Week High Change Percent -0.019572858
Fifty Two Week Low 244.52
Fifty Two Week Low Change 90.58998
Fifty Two Week Low Change Percent 0.37048087
Fifty Two Week Range 244.52 - 341.8
Financial Currency USD
First Trade Date Milliseconds 638,721,000,000
Float Shares 80,717,208
Forward Eps 19.79822
Forward P E 16.92627
Free Cashflow 892,049,984
Full Exchange Name NYSE
Full Time Employees 71,000
Fullday Change -0.710022
Fullday Change Percent -0.211429
Fullday Price 333.0
Gmt Off Set Milliseconds -14,400,000
Governance Epoch Date 1,785,542,400
Gross Margins 0.28882998
Gross Profits 4,144,100,096
Has Pre Post Market Data 1
Held Percent Insiders 0.0034999999
Held Percent Institutions 1.02356
Implied Shares Outstanding 81,100,000
Industry Diagnostics & Research
Industry Disp Diagnostics & Research
Industry Key diagnostics-research
Is Earnings Date Estimate 1
Language en-US
Last Dividend Date 1,780,012,800
Last Dividend Value 0.72
Last Fiscal Year End 1,767,139,200
Last Split Date 1,688,342,400
Last Split Factor 1,164:1000
Long Business Summary Labcorp Holdings Inc. provides laboratory services. It operates in Diagnostics Laboratories and Biopharma Laboratory Services segments. The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin A1C, PSA, tests for sexually transmitted diseases, vitamin D testing, microbiology cultures and procedures, and alcohol and other substance abuse tests. It also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target specific diseases; services related to anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, parentage and donor testing, occupational testing service, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests; and health and wellness services to employers and managed care organizations. In addition, it offers digital pathology solutions, a pathology platforms that support the digitization, centralized review, and sharing of pathology slides; provider and payer digital platforms, an online applications for providers, MCOs, and ACOs; online and mobile applications that enable patients to check offerings, schedule PSC visits, check-in upon PSC arrival, complete documentation, access tests and test results, and manage their accounts; and Generative AI enabled Test Selection, a generative AI enabled tool. It serves clients, third party, medicare/medicaid, patients, pharmaceutical, biotechnology, medical device, diagnostic companies, and CROs. It has a strategic collaboration with the Children's Hospital of Philadelphia to accelerate the discovery, development, and availability of pediatric diagnostics; a strategic alliance with the National Association of Community Health Centers to support current and emerging clinical leaders through the NACHC Leadership Exchange for Chief Medical Officers; and Alliance for Clinical Trials in Oncology to advance national clinical trial for patients diagnosed with colorectal cancer. The company was founded in 1995 and is headquartered in Burlington, North Carolina.
Long Name Labcorp Holdings Inc.
Market us_market
Market Cap 27,177,420,800
Market State CLOSED
Max Age 86,400
Message Board Id finmb_30643
Most Recent Quarter 1,782,777,600
Name Change Date 2,026-08-28
Net Income To Common 1,002,300,032
Next Fiscal Year End 1,798,675,200
Non Diluted Market Cap 27,293,394,000
Number Of Analyst Opinions 16
Open 336.39
Operating Cashflow 1,638,400,000
Operating Margins 0.1224
Overall Risk 1
Payout Ratio 0.2382
Peg Ratio 1.41
Phone 336 229 1127
Post Market Change -2.1099854
Post Market Change Percent -0.6296396
Post Market Price 333.0
Post Market Time 1,787,960,478
Prev Name Laboratory Corporation of America Holdings
Previous Close 335.82
Price Eps Current Year 18.266335
Price Hint 2
Price To Book 3.1498852
Price To Sales Trailing12 Months 1.8941609
Profit Margins 0.069860004
Quick Ratio 1.246
Quote Source Name Nasdaq Real Time Price
Quote Type EQUITY
Recommendation Key buy
Recommendation Mean 1.72222
Region US
Regular Market Change -0.710022
Regular Market Change Percent -0.211429
Regular Market Day High 337.69
Regular Market Day Low 334.42
Regular Market Day Range 334.42 - 337.69
Regular Market Open 336.39
Regular Market Previous Close 335.82
Regular Market Price 335.11
Regular Market Time 1,787,947,202
Regular Market Volume 456,542
Return On Assets 0.05527
Return On Equity 0.11728
Revenue Growth 0.058
Revenue Per Share 174.021
Sand P52 Week Change 0.20504117
Sector Healthcare
Sector Disp Healthcare
Sector Key healthcare
Share Holder Rights Risk 1
Shares Outstanding 81,100,000
Shares Percent Shares Out 0.0239
Shares Short 1,938,163
Shares Short Previous Month Date 1,784,073,600
Shares Short Prior Month 2,721,939
Short Name Labcorp Holdings Inc.
Short Percent Of Float 0.024
Short Ratio 2.57
Source Interval 15
State NC
Symbol LH
Target High Price 385.0
Target Low Price 293.0
Target Mean Price 341.5
Target Median Price 350.0
Total Cash 141,800,000
Total Cash Per Share 1.748
Total Debt 6,823,000,064
Total Revenue 14,348,000,256
Tradeable 0
Trailing Annual Dividend Rate 2.88
Trailing Annual Dividend Yield 0.008576023
Trailing Eps 12.03
Trailing P E 27.856192
Trailing Peg Ratio 1.4059
Triggerable 1
Two Hundred Day Average 273.60205
Two Hundred Day Average Change 61.507935
Two Hundred Day Average Change Percent 0.22480802
Type Disp Equity
Volume 456,542
Website https://www.labcorp.com
Zip 27,215